Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Dick

Showing results (121-130 of 178) with videos related to

Pageof 18
Sort By:
Antimicrobial Agents and Chemotherapy|November 29, 2023
Pharmacological validation of dihydrofolate reductase as a drug target in <i>Mycobacterium abscessus</i>Wassihun Wedajo Aragaw, Dereje A Negatu, Christopher J Bungard, et al.
ACS Chemical Biology|May 13, 2021
<i>Mycobacterium tuberculosis</i> PanD Structure-Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme InhibitorPriya Ragunathan, Malcolm Cole, Chitra Latka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosisUjjini H Manjunatha, Helena Boshoff, Cynthia S Dowd, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Structure-Activity Relationship of Anti-<i>Mycobacterium abscessus</i> Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase InhibitorsAndreas Beuchel, Dina Robaa, Dereje A Negatu, et al.
The Journal of Biological Chemistry|June 20, 2013
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosisJun Zheng, Eric J Rubin, Pablo Bifani, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessusDereje Abate Negatu, Andreas Beuchel, Abdeldjalil Madani, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessusUday S Ganapathy, Tian Lan, Philipp Krastel, et al.
ACS Infectious Diseases|June 22, 2022
Structural and Mechanistic Insights into <i>Mycobacterium abscessus</i> Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived InhibitorWuan-Geok Saw, Chen Yen Leow, Amaravadhi Harikishore, et al.
Antimicrobial Agents and Chemotherapy|November 29, 2022
Structural Elements Involved in ATP Hydrolysis Inhibition and ATP Synthesis of Tuberculosis and Nontuberculous Mycobacterial F-ATP Synthase Decipher New Targets for InhibitorsChui Fann Wong, Wuan-Geok Saw, Sandip Basak, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential ResistanceJohn T Williams, Elizabeth R Haiderer, Garry B Coulson, et al.
Pageof 18

Showing results (121-130 of 178) with videos related to

Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|November 29, 2023
Pharmacological validation of dihydrofolate reductase as a drug target in <i>Mycobacterium abscessus</i>Wassihun Wedajo Aragaw, Dereje A Negatu, Christopher J Bungard, et al.
ACS Chemical Biology|May 13, 2021
<i>Mycobacterium tuberculosis</i> PanD Structure-Function Analysis and Identification of a Potent Pyrazinoic Acid-Derived Enzyme InhibitorPriya Ragunathan, Malcolm Cole, Chitra Latka, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2006
Identification of a nitroimidazo-oxazine-specific protein involved in PA-824 resistance in Mycobacterium tuberculosisUjjini H Manjunatha, Helena Boshoff, Cynthia S Dowd, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Structure-Activity Relationship of Anti-<i>Mycobacterium abscessus</i> Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase InhibitorsAndreas Beuchel, Dina Robaa, Dereje A Negatu, et al.
The Journal of Biological Chemistry|June 20, 2013
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosisJun Zheng, Eric J Rubin, Pablo Bifani, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2021
Piperidine-4-Carboxamides Target DNA Gyrase in Mycobacterium abscessusDereje Abate Negatu, Andreas Beuchel, Abdeldjalil Madani, et al.
Antimicrobial Agents and Chemotherapy|July 6, 2021
Blocking Bacterial Naphthohydroquinone Oxidation and ADP-Ribosylation Improves Activity of Rifamycins against Mycobacterium abscessusUday S Ganapathy, Tian Lan, Philipp Krastel, et al.
ACS Infectious Diseases|June 22, 2022
Structural and Mechanistic Insights into <i>Mycobacterium abscessus</i> Aspartate Decarboxylase PanD and a Pyrazinoic Acid-Derived InhibitorWuan-Geok Saw, Chen Yen Leow, Amaravadhi Harikishore, et al.
Antimicrobial Agents and Chemotherapy|November 29, 2022
Structural Elements Involved in ATP Hydrolysis Inhibition and ATP Synthesis of Tuberculosis and Nontuberculous Mycobacterial F-ATP Synthase Decipher New Targets for InhibitorsChui Fann Wong, Wuan-Geok Saw, Sandip Basak, et al.
Antimicrobial Agents and Chemotherapy|August 14, 2019
Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential ResistanceJohn T Williams, Elizabeth R Haiderer, Garry B Coulson, et al.
Pageof 18